3 results match your criteria: "Clinical Research Division Fred Hutchinson Cancer Research Center Seattle Washington USA.[Affiliation]"
EJHaem
November 2022
Section of Pathology, Clinical Research Division Fred Hutchinson Cancer Research Center Seattle Washington USA.
Background: Patients with cutaneous T-cell lymphoma (CTCL) often have indolent but symptomatic disease.
Objective: Assessment of the health-related quality of life (HRQoL) of patients with CTCL.
Methods: Cross-sectional survey study.
Beneficial mutations that arise in an evolving asexual population may compete or interact in ways that alter the overall rate of adaptation through mechanisms such as clonal or functional interference. The application of multiple selective pressures simultaneously may allow for a greater number of adaptive mutations, increasing the opportunities for competition between selectively advantageous alterations, and thereby reducing the rate of adaptation. We evolved a strain of that could not produce its own histidine or uracil for ~500 generations under one or three selective pressures: limitation of the concentration of glucose, histidine, and/or uracil in the media.
View Article and Find Full Text PDF